Clinical Trials in the EU / 2024-517923-38-00
Authorised, recruiting
Phase I
A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment
2024-517923-38-00 · tracked via the Priya Life Science EU tracker
Condition studied
Newly diagnosed and/or previously treated IDH1-mutated malignancies
Eligibility
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View 2024-517923-38-00 on CTIS ↗ ← All trials in the EU